March 15, 2023 at 12:05 pm

Medical Robots Market and Packaging Robots Market Outlook and Analysis 2030 | Industry Demands, Business Overview, Size & Share, Revenue, Trends, Growth Factors, and SWOT Analysis – Extrapolate

Medical robots are assisting doctors in performing surgeries with improved accuracy and mitigate unforeseen errors whereas packaging robots are emerging as cost-effective solutions to enhance productivity and mitigate packaging waste. Medical Robots Market and Packaging Robots Market is projected to generate a staggering CAGR of 14.4% & 12.3% Resp. by the end of 2030. Dubai,… [Read More]
March 14, 2023 at 10:48 pm

META Cuts 10,000 More Jobs, Continuing Tech Layoffs

On Tuesday, Meta Platforms (formerly Facebook) announced that it will reduce its workforce by 10,000 jobs in 2023, becoming the first major tech company to initiate a second wave of mass layoffs as the industry prepares for a significant economic downturn. Following this news, Meta’s shares increased by 6%. This long-anticipated move is part of… [Read More]
March 14, 2023 at 2:04 pm

SuperCom (NASDAQ: SPCB) Revolutionizing the Criminal Justice Industry

SuperCom Ltd. (SPCB) is a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors. SuperCom presents an impressive group of experts in business, commercial, government identification and wireless technologies, which brings together decades of hands-on experience and expertise. Most recently, the company has launched a $3.6M national electronic monitoring project in Finland. [Read More]
March 14, 2023 at 11:30 am

2 Biotech Stocks Options Traders Are Watching

At least two biotech stocks are seeing increased scrutiny in the options pits, with BridgeBio Pharma, Inc. $BBIO and Esperion Therapeutics, Inc. $ESPR moving in opposite directions following their respective drug updates. BridgeBio Stock Hits 12-Month High Last seen up 61.3% to trade at $17.53 and earlier touching a more than one-year high of $19.39, BridgeBio stock… [Read More]
March 13, 2023 at 8:42 pm

Bill Ackman Predicts More Banks Will Fail

On March 12, U.S. regulators took decisive action to prevent contagion from the collapse of Silicon Valley Bank. The Treasury Department, FDIC, and Federal Reserve announced that all depositors of the failed Californian bank will receive their money in full on March 13. Additionally, the Fed is creating a new Bank Term Funding Program (BTFP)… [Read More]
March 13, 2023 at 1:14 pm

Provention Bio Shares Soar 260% Following $2.9 Billion Sanofi Deal

Commercial-stage biopharmaceutical company, Provention Bio (Nasdaq: PRVB) will be acquired by French drugmaker, Sanofi (Nasdaq: SNY) in a deal valued at $2.9 billion. Provention stock jumped 260% to reach $24.14 in premarket trading on news of the deal. Highlights In November 2022, the FDA approved Provention’s Tzield as a treatment to delay the onset of… [Read More]
March 10, 2023 at 6:19 pm

Stock Market Suffers Significant Losses After Two Key Events

On Friday, U.S. stocks experienced significant losses due to two major financial events: a stronger-than-expected February jobs report and the failure of Silicon Valley Bank (SIVB), the largest financial institution to collapse since the 2008 financial crisis. The S&P 500 and Dow Jones Industrial Average both fell by 1.4% and 1.1%, respectively, while the technology-heavy… [Read More]
March 10, 2023 at 9:41 am

SKYX Platforms Makes Second Strategic Acquisition of 2023

Platform technology company, SKYX Platforms (Nasdaq: SKYX), has acquired Bailey Street Home, a $5 million revenue, profitable, strategic e-commerce private label lighting website. The acquisition is in addition to the company’s February 2023 acquisition of Belami, Inc., a lighting and décor conglomerate with $86 million in revenues. The deal was funded by two of SKYX’s… [Read More]
March 09, 2023 at 3:19 pm

2 Biotech Stocks Options Traders Are Watching

At least two biotech stocks are seeing increased scrutiny in the options pits, with BridgeBio Pharma Inc (NASDAQ:BBIO) and Esperion Therapeutics Inc (NASDAQ:ESPR) moving in opposite directions following their respective drug updates. BridgeBio Stock Hits 12-Month High Last seen up 61.3% to trade at $17.53 and earlier touching a more than one-year high of $19.39, BridgeBio stock is set… [Read More]
March 08, 2023 at 8:22 pm

California Ends Walgreens Contract After Abortion-Pill Dispute

California Governor Gavin Newsom has canceled a $54 million contract with Walgreens after the pharmacy chain declined to sell an abortion pill by mail in some conservative-led states. The contract, which was set to expire on April 30, covered the supply of specialty pharmacy prescription drugs to California’s prison health care system, including medication used… [Read More]